DIABETES FOR THE CARDIOVASCULAR CLINICIAN

Presenter(s)

• 

  Kim Connelly, MD, FRACP, PhD, MBBS

  Director, Krembil Stem Cell Facility
  University of Toronto

Learning Objectives

At the conclusion of this session, participants will be able to:

• examine the role of new therapeutic agents for heart failure (HF), diabetes and the intersection of these two disease epidemics.